Studies [50] have suggested that compared to Tregs in peripheral blood, tumor-infiltrating Tregs exhibit more proliferative and immunosuppressive phenotypes, with increased expression of CTLA-4, CD25, GITR, 4−1BB, OX40, ICOS, LAG-3, TIM3, TIGIT, and PD-1. Here, TNFRSF18 is linked to neoplasm.